(Q41734186)

8 October 2017

1 reference

title

Treatment of Graves' disease: the American way. (English)

1 reference

8 October 2017

1 reference

Levy EG

1

1 reference

8 October 2017

publication date

1 October 1997

1 reference

Bailliere's clinical endocrinology and metabolism

8 October 2017

published in

1 reference

8 October 2017

volume

11

1 reference

8 October 2017

issue

3

1 reference

8 October 2017

page(s)

585-595

1 reference

Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980798-7

7 January 2021

The management of hyperthyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980798-7

7 January 2021

Radioiodine treatment of Graves' disease. An assessment of its potential risks

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980798-7

7 January 2021

Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980798-7

7 January 2021

Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyper-thyroidism and back to hypothyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980798-7

7 January 2021

Use of radioiodine in the management of hyperthyroidism in the UK: development of guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980798-7

7 January 2021

A clinical guide to the management of Graves' disease with radioactive iodine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980798-7

7 January 2021

Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980798-7

7 January 2021

Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980798-7

7 January 2021

Maternal hyperthyroidism and congenital malformation in the offspring

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980798-7

7 January 2021

Reevaluation of the effects of methylmercaptoimidazole and propylthiouracil in patients with Graves' hyperthyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980798-7

7 January 2021

The medical management of Graves' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980798-7

7 January 2021

Use of adjunctive potassium iodide after radioactive iodine (131I) treatment of Graves' hyperthyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980798-7

7 January 2021

Long-term Antithyroid Treatment in Hyperthyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980798-7

7 January 2021

Remission rates with antithyroid drug therapy: continuing influence of iodine intake?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980798-7

7 January 2021

Current Trends in the Management of Graves' Disease*

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980798-7

7 January 2021

International differences in approaches to 131I therapy for Graves' disease: case selection and restrictions recommended to patients in Japan, Korea, and China

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980798-7

7 January 2021

Radioiodine therapy for Graves' disease: case selection and restrictions recommended to patients in North America

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980798-7

7 January 2021

Differences and Similarities in the Diagnosis and Treatment of Graves' Disease in Europe, Japan, and The United States

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2897%2980798-7

7 January 2021

10.1016/S0950-351X(97)80798-7

Identifiers

DOI

1 reference

8 October 2017

1 reference